AAIC Satellite Symposium: Buenos Aires, Argentina April 17-18, 2018 Sheraton Libertador Hotel Grand Bourg Ballroom

Similar documents
Sao Paulo, Brazil April 10-12, :30-10 a.m. Current Trends and Challenges on Dementia Practice in Latin America Ricardo Nitrini (Brazil)

Arg-ADNI. Gustavo E. Sevlever, Silvia Vázquez, Deborah R. Gustafson, Salvador M. Guinjoan, Ricardo F. Allegri(*) and Arg-ADNI group.

Arg-ADNI. WW-ADNI update, Boston, July 12, 2013

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Alzheimer s Association: Public Health Perspectives & Initiatives

REPORT TO THE INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Form D1: Clinician Diagnosis

1 st LATIN AMERICA COUNTRIES MEETING - BRIEF REPORT INSTITUTO LATINOAMERICANO DE SEPSIS - ILAS SÃO PAULO MAY 30 th 2018

Target audience. Jorge Correale Department of Neurology Raúl Carrea Institute for Neurological Research (FLENI) Buenos Aires, Argentina

Broadening horizons: medical nutrition for managing early Alzheimer s disease

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

MISMS Latin America Influenza Meeting and Training Workshop June 25-28, 2012 Estelar Hotel Miraflores Lima, Peru

1st International Hands-on course in skull base surgery & cerebro vascular of Hospital Juárez de México. México city

10 Signs of AD. Sources for Information and Support. Inside this issue: National Centralized Repository. Alzheimer s Disease and Related Dementias

This event has CPD accreditation. #AlzheimersESC

1st Iberoamerican Congress of Neuropsychology. June 1-4, 2016, 2016 at the Bilbao Exhibition Centre - BEC

2 nd Annual GBHI Conference Barcelona, Spain April 19 22, 2017

26 November Lima, Perù

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Latin American Human Papillomavirus Symposium April 2018 Catholic Argentine University Auditorium Buenos Aires Argentina. Preliminary Program

Genetic Disorders and Congenital Defects in Latin America and the Caribbean

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

FOCIS goes South: ADVANCES IN TRANSLATIONAL AND CLINICAL IMMUNOLOGY

ADC Directors Meeting

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD Secretariat for Multidimensional Security

Dementia is not normal aging!

PSG 30th Annual Meeting & PSG 32nd Annual Symposium. Friday, April 5 - Monday, April 8, 2019

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

Clinical Practice Guidelines, Development and Implementation in Mexico, International Forum

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

2 nd International Conference On DEMENTIA AND DEMENTIA CARE. Dementia April 15-16, 2019 Toronto, Canada

7 November Buenos Aires, Argentina

Regional Workshop on Dementia Final Report October 2017 Santo Domingo

The Cuban Study of Aging and Dementia

Biomarkers of Neuroinflammation: A Workshop

TUESDAY, MARCH 28, 2017 WEDNESDAY, MARCH 29, 2017 WELCOME RECEPTION (VIENNA CITY HALL)

Mild Cognitive Impairment Symposium January 19 and 20, 2013

Appendix e-1. Contents. S1. This Opinion Paper in a Geographical Context. S2. Origin of this Opinion Paper. S3. Demographic Transition in LAC

Gastrointestinal Oncology

BrightFocus Alzheimer s Fast Track

Claims & Underwriting. You already told us that story! Maria C. Carrillo, Ph.D. Sr. Director, Medical & Scientific Relations Alzheimer s Association

Primary Care Workshop Agenda

AANP. American Association of Neuropathologists. 93 rd Annual Meeting. June 8-11 Orange County, California. Meeting at a Glance

Roche satellite symposium/educational session CTAD Asia - China Conference Transforming AD in China: From Diagnosis to Treatment

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

SESSION 1: IMMUNE CHECKPOINTS: MECHANISMS AND THERAPEUTIC OPPORTUNITIES Grand Ballroom I/II

Report and Action Plan

First Scientific Symposium Translational Research in Alzheimer. Paris - September 18, 2009 Collège de France

DEMENTIA IN THE AMERICAS. CURRENT AND FUTURE COST AND PREVALENCE OF ALZHEIMER S DISEASE AND OTHER DEMENTIAs. bupa.com/dementia alz.co.

LOCAL AND INTERNATIONAL COMMITTEES

Form A3: Subject Family History

ALZHEIMER'S DISEASE PREVENTION TRIALS

Tau Mechanism in Dementia

Dementia in Latin America Assessing the present and envisioning the future

Dementia, Cognitive Aging Services and Support

Conference Program. STS/EACTS Latin America Cardiovascular Surgery Conference. November 15-17, 2018 Cartagena, Colombia

Contents. Introduction. Introduction 03

Clinical Genetics & Dementia

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Stephen Salloway, M.D., M.S. Disclosure of Interest

Current Issues and Initiatives in Alzheimer s Research and Services. Disclosure. I have no relevant financial relationships to disclose

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

II Neurobiology Meeting, 2017 Sociedad Mexicana de Bioquímica, A.C. Querétaro, Qro., México

Theme Topics Subtopics. Basic and Translational Science. Development of New Models and Analysis Methods

II Neurobiology Meeting, 2017 Sociedad Mexicana de Bioquímica, A.C. Querétaro, Qro., México

State of the Art in the Prevention and Control of Dengue in the Americas May, 2014 Washington DC, USA

Regional Update EW 30 Influenza (August 9, h GMT; 12 h EST)

Early Intervention and Diagnosis in Paediatric Neurodevelopment Defects in Brazil, November, Rio de Janeiro, Brazil

Breakfast and Registration. Welcome and Introductions Luis E. Raez (USA), Eduardo Richardet (Argentina) Pre-meeting Test

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada

SPONSORSHIP OPPORTUNITIES

Implementing Standards in Training in Latin America

Diversity and Dementia

Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy

Cervical Cancer Situation in Latin America and the Caribbean and PAHO/WHO Recommendations for the Way Forward

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

Australia Lisbeth Evered, Ph.D. Biomarker evidence of neuronal damage in response to anesthesia and surgery Matthew Pase, Ph.D.

Tammie Benzinger, MD, PhD

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

The NCD Café. The Spirit of Partnership: Collaborating to Achieve 25X25 on Cardiovascular Disease and other NCDs

IMPACT OF THE INTERNATIONAL PARKINSON AND MOVEMENT DISORDER SOCIETY SCHOOLS IN YOUNG NEUROLOGISTS CAREERS: RESULTS FROM A WEB-BASED SURVEY

! slow, progressive, permanent loss of neurologic function.

Sandra Weintraub, PhD Clinical Core Leader and Professor

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

October Costa Mesa

Course Program. São Paulo, BRAZIL N OV E MB E R 9-1 0, Ataxias and Spastic Paraplegias: From Molecular Biology to Bedside and Treatment

2018 Alzheimer s Association Grant Awards

Molecular Imaging Heterogeneity of Clinically Defined AD

Functional neural correlates of anosognosia in Alzheimer s disease. University Medical Center Groningen

Neuroinflammation in preclinical AD: in vivo evidence

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease

2016 California Behavioral Health Policy Forum

Transcription:

AAIC Satellite Symposium: Buenos Aires, Argentina April 17-18, 2018 Sheraton Libertador Hotel Grand Bourg Ballroom Day 1 8:00a.m. 9:00-9:45a.m. Name Badge & Meeting Material Pick-up Begins Welcome Harry Johns, President & CEO, Alzheimer s Association Maria Carrillo, Chief Science Officer, Alzheimer s Association Remarks from A.L.M.A. Noemi Medina, Vice President, A.L.M.A Session 1: Epidemiology of AD & Dementia in Latin America Session Chair & Discussion Moderator: Ricardo Nitrini (Brazil) 9:45-10:00a.m. 10:00-10:15a.m. 10:15-10:55a.m. 10:55-11:20a.m. 11:20-11:40a.m. 11:40-12:10p.m. 12:10-12:25p.m Alzheimer s Disease International: Global Prevalence of Alzheimer s Paola Barbarino (U.K.) Latin America Epidemiology of Alzheimer s & Dementia Nilton Custodio (Peru) Moderated Discussion: Ricardo Nitrini, Brazil Nilton Custodio, Peru Daisy Acosta, Dominican Republic Ana Luisa Sosa, Mexico Gladys Maestre, U.S./Venezuela Paola Barbarino, Alzheimer s Disease International Perspective: WHO Pan American Health Organization (PAHO) Devora Kestel (U.S.) Keynote: NIA-AA Research Framework Clifford Jack (U.S.) Industry Perspective on the NIA-AA Research Framework Samantha Budd Haeberlein (U.S.)

12:25-1:25p.m. 1:25-2:40p.m. Rapid Fire Poster Presentations Poster Presenters Attached Moderators: Jose Abisambra & Yakeel Quiroz LUNCH & POSTER PRESENTATIONS Session 2: Imaging Biomarkers: Advances & Implementation Session Chair & Discussion Moderator: Janus Kremer (Argentina) 2:40-2:50p.m. 2:50-3:00p.m. 3:00-3:15p.m. 3:15-3:30p.m. 3:30-3:45p.m. 3:45-4:10p.m. 4:10-4:30p.m. MRI in Alzheimer s & Dementia Research Yakeel Quiroz (U.S./Colombia) MRI in Clinical Use for Alzheimer s & Dementia in Latin America Ismael Calandri (Argentina) Advances in PET Imaging: PIB, Amyloid, Tau & Emerging Modalities Victor Villemagne (Australia) Implementation of PET in Argentina Silvia Vazquez (Argentina) Implementation of PET: Multitracer Approach at CUDIM Andres Damian (Uruguay) Panel of Session 2 Speakers + Merce Boada (Spain) Session 3: Biochemical Biomarkers: Advances & Implementation Session Chair & Discussion Moderator: Gustavo Sevlever (Argentina) 4:30-4:45p.m. 4:45-5:00p.m. 5:00-5:15p.m. 5:15-5:35p.m. 5:35-6:25p.m. 6:25-6:30p.m. BioFluids in Alzheimer s: Appropriate Use Criteria for CSF Jose Luis Molinuevo (Spain) Challenges in the Development of New Biomarkers in Other BioFluids: Reality of implementation Ezequiel Surace (Argentina) Integration Across Imaging & Biochemical Platforms: FLENI Ricardo Allegri (Argentina) Panel of Session 3 Speakers Validation of the NIA-AA Research Framework Across Latin America Discussion Moderator: Maria C. Carrillo (United States) Panelists: Eric Siemers (U.S.) Clifford R. Jack (U.S.) Ricardo Allegri (Argentina) Jose Luis Molinuevo (Spain) Jalayne Arias (U.S.) Gustavo Sevlever (Argentina) Alzheimer Argentina Luis Ignacio Brusco, Alzheimer Argentina

6:30-6:40p.m. Close of Day 1 Heather M. Snyder, Alzheimer s Association 6:45-8:30p.m. RECEPTION: ALL ATTENDEES DAY 2: 8:45-9:00a.m. 9:00-9:15a.m. 9:15-9:30a.m. 9:30-10:30a.m. 10:30-11:05a.m. 11:05-11:30a.m. Overview of Day One Gustavo Sevlever (Argentina) PAMI s Strategic National Plan for Brain Health, Alzheimer s Disease and other Dementias Julian Bustin (Argentina) GBHI Overview Victor Valcour (U.S.) Rapid Fire GBHI Poster Presentations Poster Presenters Attached Moderators: Bruce Miller (U.S.) & Mary Sano (U.S.) Keynote Introduction: Mary Sano (U.S.) Keynote: Considerations of Brain Health: Risk for Dementia & Health Equity in Latin America Facundo Manes (Argentina) Session 4: Contributions to Brain Health & Dementia Risk Session Chair & Discussion Moderator: Jose Abisambra (U.S.) 11:30-11:45a.m. 11:45-12:00p.m. 12:00-12:15p.m. 12:15-12:30p.m. 12:30-12:55p.m. 12:55-2:10p.m. Literacy, Memory & Brain Connectivity Elisa de Paula Franca Resende (Brazil/USA) Non-Alzheimer s Contributions to Cognition Oscar Lopez (U.S) Vascular Contributions to Brain Health Lea Grinberg (U.S) Risk Factors in Dementia with Lewy Bodies Angel Golimstok (Argentina) Panel of Session 4 Speakers & Keynote LUNCH & POSTER PRESENTATIONS Session 5: Emerging Therapeutics & Lifestyle Interventions Session Chair & Discussion Moderator: Khalid Iqbal (U.S.) 2:10-2:25p.m. Targeting Tau as a Possible Therapy for Alzheimer s Alejandra Alonso (U.S.)

2:25-2:40p.m. 2:40-2:55p.m. 2:55-3:10p.m. 3:10-3:25p.m. 3:25-3:50p.m. 3:50-4:10p.m. Targeting Axonal Transport Dysfunction in Alzheimer s Tomas Falzone (Argentina) Molecular mechanisms involved in early neuronal bioenergetics dysfunction Laura Morelli (Argentina) How Exercise May Correct Memory Deficits in Models of AD Sergio Ferreira (Brazil) Typical and non-typical approaches to Therapy Development in Alzheimer s Nibaldo Inestrosa (Chile) Panel of Session 5 Speakers Session 6: Clinical Studies in Sporadic and Dominantly Inherited Alzheimer s Populations Session Chair & Discussion Moderator: Ruben Vidal (U.S.) 4:10-4:25p.m. 4:25-4:40p.m. 4:40-4:55p.m. 4:55-5:10p.m. 5:10-5:25p.m. 5:25-5:45p.m. 5:45pm. Mild Behavioral Impairment in Argentina Fernando E. Taragano (Argentina) Rare Coding Variants in Sporadic AD in South America Alfredo Ramirez (Germany/Chile) DIAN Families in Latin America Patricio Chrem Mendez (Argentina) Colombian Kindred Francisco Lopera (Colombia) Down Syndrome & Alzheimer s Disease Cynthia Lemere (U.S.) Panel of Session 6 Speakers Close of Meeting

Day 1, April 17, 2018 Rapid Fire Poster Presentations Moderators: Jose Abisambra, PhD (US) & Yakeel Quiroz, PhD (US) Poster Presenters: Paula Desplats, PhD University of California San Diego Cross-Talk Between DNA Methylation and Circadian Rhythms: When the Clock is Off in the Alzheimer's Brain. Karen Dorsman, BA University of California, San Francisco Characteristics of cognitively impaired Spanish-speaking individuals of Hispanic origin in the NACC database German Falasco, Eng. Centro de Imagenes Moleculares, FLENI Brain asymmetries in normal and pathological aging: A molecular imaging perspective Gonzalo A. Farias MD, PhD Department of Neurosciences, Universidad de Chile and International Center for Biomedicine (ICC). Tau in platelets as a biomarker for Alzheimer's disease and related neurodegenerative conditions Lionel M. Igaz, PhD University of Buenos Aires School of Medicine, Buenos Aires, Argentina Evaluation of behavioral phenotypes before and after transgene suppression in a conditional TDP-43 mouse model of Frontotemporal dementia /Amyotrophic lateral sclerosis. Tatiana Itzcovich, MSc FLENI A novel mutation in PSEN1 (p.t119i) in an Argentine family with early and late-onset Alzheimer's disease Renata R Kochhann, PhD Pontifical Catholic University, Sao Paulo, Brazil Self versus proxy-evaluated functionality: which has a stronger relation with white and gray integrity in patients with Alzheimer's disease? Alfredo Lorenzo, PhD INIMEC-CONICET- Universidad Nacional de Córdoba APP/Go protein G-beta-Gamma complex signaling mediates AB degeneration and cognitive impairment in rat and human models of Alzheimer's disease MB Bistue Millon, PhD ICBM, Catholic University of Cuyo / CONICET, San Juan, Argentina Role of LSD1 in inflammation and Cognition in a Transgenic Rat Model of AD-like pathology. Sebastian Moguilner, M.Sc. INECO Weighted Symbolic Dependence Dynamics (wsdd) for fmri resting-state connectivity: A multicentric validation for frontotemporal dementia

DAY 2, April 18, 2018 Rapid Fire GBHI Poster Presentations Moderators: Bruce Miller (U.S.) & Mary Sano (U.S.) Jalayne J. Arias, JD Memory and Aging Center, Department of Neurology, UCSF A New Model for Long-term Care Insurance and Financing Long-term Care Services and Supports Eléonore Bayen, M.D., Ph.D. Brain Health matters : create optimism and understanding around dementia and brain health at school Alissa S. Bernstein, Ph.D., MPH Mapping the Dynamics of Caregiver Burden in Alzheimer's Disease Dominic Campbell, BA Creative Aging International - Celebration as Strategy Laurent Cleret de Langavant, M.D., Ph.D. Department of Neurology, Paris Est University Statistical learning to track dementia in population-based surveys Bárbara Costa Beber, Ph.D. Speech and Language Therapy Department, UFCSPA, Brazil Investigation of the topic of dementia in the curricula of Speech and Language Therapy undergraduate programs in Brazil - Preliminary results Elissaios Karageorgiou, M.D., Ph.D. Memory and Aging Center, UCSF Cognitive Behavioral Therapy for Insomnia in Mild Cognitive Impairment Jorge J Llibre Guerra, M.D., MSc National Institute of Neurology, La Habana, Cuba Ancestry Background: Implications for Cognitive Decline and Mortality in Dementia. Rogerio Panizzutti, M.D., Ph.D Instituto de Ciências Biomedicas, Universidade Federal do Rio de Janeiro Digital cognitive training to promote brain health: implementation and engagement Elisa PF Resende, M.D. Faculty of Medicine, Universidade Federal de Minas Gerais Literacy and memory: Any amount matters and it is never too late to improve.

Adrià Rofes, Ph.D. Word properties of fluency tasks in three variants of Primary Progressive Aphasia Fionnuala Sweeney B.A. (Hons.) H.Dip. Ed Your Brain's Health Ioannis Tarnanas, Ph.D. Prognostic Digital Biomarkers for MCI due to AD Stelios Zygouris, MSc Medical School, Aristotle University of Thessaloniki A two-tiered cost-efficient computerized cognitive screening protocol